Tamoxifen vs. Inhibidores de aromatasa para cáncer de mama: análisis de costo efectividad para Colombia

Liliana Chicaíza, Oscar Gamboa and Mario García

Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID

Abstract: To conduct a cost-effectiveness analysis comparing tamoxifen and aromatase inhibitors in adyuvant treatment of hormone receptor-positive, post-menopausal early breast cancer patients.

Keywords: Cost-Benefit Analysis; Breast cancer; Health Economics (search for similar items in EconPapers)
JEL-codes: D61 I10 I19 (search for similar items in EconPapers)
Pages: 12
Date: 2011
References: Add references at CitEc
Citations:

Published in Econografos

Downloads: (external link)
https://fce.unal.edu.co/centro-editorial/documento ... ocumentos-EACP-2.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:col:000176:022904

Access Statistics for this paper

More papers in Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID Contact information at EDIRC.
Bibliographic data for series maintained by Facultad de Ciencias Económicas Unal ().